Analytical Data
-
Gene name
Clec4g
- Application
-
Alternative Names
/
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8BNX1
-
Expression Region
52-294aa
-
Molecular Weight
31.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Clec4g, also known as C-type lectin domain family 4 member G, is a receptor that plays a crucial role in the immune system, particularly in recognizing and responding to pathogens. Its importance lies in its ability to identify specific sugars on the surface of viruses and bacteria, facilitating their uptake by immune cells. Research on Clec4g has gained momentum due to its potential implications in understanding immune responses and developing therapeutic strategies for infectious diseases and autoimmune conditions. Recent studies have focused on the structural characterization and functional analysis of Clec4g, aiming to explore its ligand binding properties and signaling pathways. This involves generating recombinant Clec4g proteins to investigate their interactions with various pathogens and elucidating their role in modulating immune responses. These studies contribute to our knowledge of innate immunity and may inform the design of vaccines and immunotherapies, highlighting the significance of Clec4g in maintaining host defense mechanisms and its potential as a target for novel treatments.
